Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
Tegaserod is a medicine for short term treatment of women who have irritable bowel syndrome (IBS) with constipation (not enough or hard bowel movements) as their main bowel problem. Tegaserod is also used to treat women younger than 55 years of age who have chronic constipation with an unknown cause. Tegaserod increases the movement of stools (bowel movement) through the bowels. Tegaserod does not cure irritable bowel syndrome. Tegaserod decreases pain and discomfort in the abdominal area, bloating, and constipation. If you stop taking tegaserod your irritable bowel syndrome symptoms may return in one to two weeks.
This medicine is available only for use in emergency situations.
This medicine was withdrawn from the U.S. market on March 30, 2007, due to a higher chance of heart attack, stroke, and worsening chest pain that can become a heart attack in patients treated with this medicine compared to placebo (sugar pills) . On July 27, 2007, this medicine was made available under a restricted access program called treatment IND; however, as of April 2, 2008, this medicine is no longer available under a treatment IND, and is only available for use in emergency situations. For further information and to see if you qualify for treatment with tegaserod for emergency use, you should consult your doctor. Your doctor will then contact FDA's Division for Drug Information about the emergency IND process at firstname.lastname@example.org .